20248 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids Retinoic acids Salts thereof
Skin Solution with Solubilized Bakuchiol
#302Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
#303CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF
#304Topical formulation
#305WOUND HEALING
#306Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
#307NONSTEROIDAL IMMUNOMODULATING KIT AND COMPOSITION AND USES THEREOF
#308Synthesis of cell penetrating peptides for drug delivery and stem cell applications
#309Method for producing therapeutic corneal endothelial substitute cell sphere
#310Composition and method for treating skin conditions
#311Compositions and methods for skin care
#312Pharmaceutical compositions for treating acne
#313METHODS OF USE TO ORALLY AND TOPICALLY TREAT ACNE AND OTHER SKIN CONDITIONS BY ADMINISTERING A 19-NOR CONTAINING VITAMIN D ANALOG WITH OR WITHOUT A RETINOID
#314ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
#315LOW DOSE ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
#316Composition and method for treating neuronal ceroid lipofuscinosis
#317Decubitus Ulcer Salve
#318METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMOR
#319COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
#320Method of reducing scarring
#321Compositions and methods to affect skin irritation
#322Methods of treating lymphoma using thienotriazolodiazepine compounds
#323ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
#324DELIVERY SYSTEMS
#325Method for the identification of immunotherapy-drug combinations using a network approach
#326METHOD FOR REGULATING ALDEHYDE DEHYDROGENASE 1
#327Phosphoserine containing compositions for immune tolerance induction
#328Biomarkers for Pin1-associated disorders
#329ATRA for modulating Pin1 activity and stability
#330Anti-aging compositions and methods for using same
#331Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition
#332Low dose oral pharmaceutical composition of isotretinoin
#333LIQUID DOSAGE FORMS OF ISOTRETINOIN
#334Method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients
#335Semifluorinated alkane compositions
#336COMPOSITIONS AND METHODS FOR TREATING MACULAR DEGENERATION
#337ENHANCED ATRA-RELATED COMPOUNDS DERIVED FROM STRUCTURE-ACTIVITY RELATIONSHIPS AND MODELING FOR INHIBITING PIN1
#338Combination therapies with anti-CD38 antibodies
#339Use of retinoic acid and analogs thereof to treat central neural apneas
#340Combination therapy for head and neck cancer
#341Composition and methods of treating acne and photoaging
#342Topical film delivery system
#343Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#344Topical film delivery system
#345COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION-ASSOCIATED DISORDERS OF THE GASTROINTESTINAL TRACT
#346Pharmaceutical compositions comprising silica microspheres
#347Composition comprising a diindolylmethane and a retinoid to treat a skin condition
#348FORMULATION FOR RETINOID-CONTAINING SOFT GELATIN CAPSULES
#349Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
#350Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#351ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
#352Topical solution of isotretinoin
#353Particle formulations of all-trans retinoic acid and transforming growth factor beta for the treatment of type 1 diabetes mellitus
#354COMBINATION THERAPY WITH RAR ALPHA AGONISTS FOR ENHANCING TH1 RESPONSE
#355Combination of an arsenic compound and at least one retinoid for treating acute myeloid leukemia
#356Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use of same in dermatology
#357METHOD FOR PREPARING LIPOSOMES OF RETINALDEHYDE OR OTHER PRECURSORS OF RETINOIC ACID AND PRODUCT THUS OBTAINED
#358GENE BIOMARKER TO DIAGNOSE METASTIC LIVER CANCER AND METHODS FOR TARGETING THE SAME
#359Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics
#360COMPOSITIONS AND METHODS FOR TOLERIZING THE IMMUNE SYSTEM TO ALLERGENS
#361Methods and systems for material transport across an impermeable or semi-permeable membrane via artificially created microchannels
#362Medium for preparing a neural cell and usage thereof
#363Vaults engineered for hydrophobic drug delivery
#364METHODS OF USE TO ORALLY AND TOPICALLY TREAT ACNE AND OTHER SKIN CONDITIONS BY ADMINISTERING A 19-NOR CONTAINING VITAMIN D ANALOG WITH OR WITHOUT A RETINOID
#365Light-activatable polymeric nanoparticles
#366Medicament for treatment of Alzheimer's disease
#367ROSACEA TREATMENTS AND KITS FOR PERFORMING THEM
#368NUTRACEUTICAL COMPOSITION AND METHODS FOR PREVENTING OR TREATING MULTIPLE SCLEROSIS
#369Delivery systems
#370NON-AEROSOL FOAMS FOR TOPICAL ADMINISTRATION
#371Oral pharmaceutical composition of isotretinoin
#372ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
#373Oral pharmaceutical composition of isotretinoin
#374Method of viral inhibition
#375Combination Therapies with Anti-CD38 Antibodies
#376Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells
#377Minoxidil for suppressing androgen receptor function
#378COMPOSITIONS AND METHODS FOR TREATING DYSPROLIFERATIVE DISEASES
#379Composition and methods for treating skin conditions
#380SYSTEM, RETAINER AND METHOD OF PROVIDING THERAPEUTIC TREATMENT FOR ACNE
#381Dental and medical devices with light source and antimicrobial solution
#382Methods of treating diseases associated with high-fat diet and vitamin A deficiency using retinoic acid receptor agonists
#383SECRETORY IMMUNOGLOBULIN DEFICIENCY TREATMENT AND PROPHLAXIS
#384COMPOSITIONS FOR PROMOTION OF WOUND HEALING AND/OR SCAR REDUCTION
#385Composition and method for treating neuronal ceroid lipofuscinosis
#386Use of maleimide derivatives for preventing and treating leukemia
#387Combination therapeutics and methods for the treatment of neurodegenerative and other diseases
#388PROCESS AND MATERIALS FOR MEDICAL APPLICATIONS
#389RETINOIC ACID MICRONEEDLE
#390Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
#391Formulation for retinoid-containing soft gelatin capsules
#392METHOD OF PREPARING RESIN TINCTURES
#393Semifluorinated alkane compositions
#394TOPICAL RETINOID FORMULATIONS, PROCESSES FOR MAKING AND METHODS OF USE
#395NOVEL METHOD OF USE
#396COMPOSITIONS AND METHODS FOR TREATING DISEASE
#397NOVEL CORE-SHELL NANOPARTICLES FOR ORAL DRUG DELIVERY
#398Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing the same, process for preparing the same and use thereof in dermatology
#399Cream gels comprising at least one retinoid and benzoyl peroxide
#400Formulations and methods for treatment of acne and inflammatory skin conditions
#401Formulations and methods for treatment of inflammatory skin diseases
#402Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
#403Pharmaceutical compositions comprising silica microspheres
#404Cationic Liposomal Drug Delivery System for Specific Targeting of Human CD14+ Monocytes in Whole Blood
#405Controlled release formulations for the induction and proliferation of blood cells
#406Formulations and methods for treatment of wounds and inflammatory skin conditions
#407TREATMENT OF EPITHELIAL LAYER LESIONS
#408Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
#409Methods and compositions for the treatment of proliferative disorders
#410DERIVATIZED POLYGLUCOSAMINES FOR DELIVERY OF SMALL MOLECULES, PEPTIDES, AND PROTEINS
#411Esters for treatment of ocular inflammatory conditions
#412Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same
#413Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
#414Mycophenolic acid analogues as anti-tumor chemosensitizing agents
#415PKC activators and combinations thereof
#416Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#417Methods Of Treating Acute Kidney Injury With Retinoic Acid
#418Compositions including encapsulated isotretinoin and methods for use thereof
#419Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#420TREATMENT OF ORAL LICHEN PLANUS WITH A COMBINATION OF TRIAMCINOLONE AND RETINOIC ACID
#421Foamable suspension gel
#422Composition Comprising Retinol, a Precursor or a Reaction Product of it and a Plant Extract from at least one Chamomilla Plant for the Treatment of Cancer
#423Methods for the treatment of immune disorders
#424Formulation for retinoid-containing soft gelatin capsules
#425Prevention and treatment of inflammatory conditions
#426Topical skin care composition
#427Uniform field magnetization and targeting of therapeutic formulations
#428MEDICAL DRESSING FOR RESPIRATORY EPITHELIAL CELLS
#429Tetracycline topical formulations, preparation and uses thereof
#430Composition comprising a diindolylmethane and a retinoid to treat a skin condition
#431Topical pharmaceutical foam composition
#432Pharmaceutical semi-solid composition of isotretinoin
#433STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT
#434Methods and compositions for the treatment of proliferative disorders
#435MOLECULAR MODULATORS OF THE WNT/BETA-CATENIN PATHWAY
#436Topical compositions for treatment of skin conditions
#437RETINOIDS AND USE THEREOF
#438Composition comprising Retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer
#439Composition and Method for Enhancing an Immune Response
#440Treatment of inflammatory and infectious skin disorders
#441Methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin D analog with or without a retinoid
#442EXCIPIENT SYSTEM FOR TOPICAL DELIVERY OF PHARMACEUTICAL AGENTS
#443Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins
#444Nanospheres for therapeutic agent delivery
#445SYNERGISTIC INTERACTION OF AT LEAST ONE VITAMIN E COMPONENT AND TYROSINASE INHIBITORS FOR DERMATOLOGICAL APPLICATIONS
#446METHOD FOR STEM CELL DIFFERENTIATION IN VIVO BY DELIVERY OF MORPHOGENES WITH MESOPOROUS SILICA AND CORRESPONDING PHARMCEUTICAL ACTIVE INGREDIENTS
#447Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
#448Foamable suspension gel
#449Compositions for topical treatment of medical conditions including wounds and inflammation
#450PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME
#451Polymeric topical compositions
#452Topical compositions for treatment of skin conditions
#453Pharmaceutical semi-solid composition of isotretinoin
#454Compositions And Methods For Treating Or Preventing Immuno-Inflammatory Disease
#455Pharmaceutical semi-solid composition of isotretinoin
#456POTENTIATION INDUCED BY PDE4 INHIBITORS IN THE TREATMENT OF LEUKEMIA
#457Compounds and Methods for the Treatment of Cancer
#458Medicinal agent for prevention and/or treatment of hepatocellular carcinoma
#459Combined use of PRAME inhibitors and HDAC inhibitors
#460Uniform field magnetization and targeting of therapeutic formulations
#461Stabilized topical formulations containing core-shell microcapsules
#462Methods for treating obesity or an obesity related condition
#463DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE REINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE
#464Rosacea treatments and kits for performing them
#465Compounds and compositions for treating infection
#466Cosmetic and pharmaceutical composition comprising N-acetylglucosamine-6-phosphate
#467Topical foam composition
#468Uniform Field Magnetization and Targeting of Therapeutic Formulations
#469Esters for treatment of ocular inflammatory conditions
#470Topical foam composition
#471Esters for treatment of ocular inflammatory conditions
#472CANCER THERAPY
#473METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION
#474DERMATOLOGICAL/COSMETIC SKIN DEPIGMENTING COMPOSITIONS
#475Compositions that treat or inhibit pathological conditions associated with inflammatory response
#476Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
#477Compositions for topical application comprising a peroxide and retinoid
#478Topical skin care composition
#479Topical retinoid solutions
#480LIQUID DOSAGE FORMS OF ISOTRETINOIN
#481Compositions and Methods for Treating Neurologic Disorders
#482MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION
#483Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#484Replenishing body stores of fat-soluble vitamins A, and D eradicate chronic viral infection
#485METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC FATIGUE SYNDROME
#486Liposome and personal care composition comprising thereof
#487DELIVERY OF AN ACTIVE DRUG TO THE POSTERIOR PART OF THE EYE VIA SUBCONJUNCTIVAL OR PERIOCULAR DELIVERY OF A PRODRUG
#488Composition for skin improvement comprising hexamidines and retinoids
#489COMPOSITION FOR RESTORATION OF AGE RELATED TISSUE IN THE FACE OR SELECTED AREAS OF THE BODY
#490Treatment of Dermatologic Skin Disorders
#491Topical Pharmaceutical Foam Composition
#492Method for Increasing the Production of a Specific ACYL-Chain Dihydroceramide(s) for Improving the Effectiveness of Cancer Treatments
#493Ophthalmic solution for protecting internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
#494Aqueous retinoid and benzoyl peroxide gel
#495COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS
#496Ophthalmic composition
#497Polymeric topical compositions
#498LYMPHOCREME
#499Ophthalmic composition
#500Methods of treatment using anti-IL-20 antibodies
#501METHODS AND COMPOSITIONS FOR DISEASE TREATMENT USING INHALATION
#502Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
#503ANTI-OXIDANT LOZENGES FOR THE PREVENTION AND TREATMENT OF RADIATION INDUCED MUCOSITIS, PRECANCEROUS LESIONS, ORAL CANCER AND OTHER ORAL CAVITY MUCOSAL DISORDERS
#504TARGETING PULMONARY EPITHELIUM USING ADRP
#505LIPOSOMES FOR DRUG DELIVERY AND METHODS FOR PREPARATION THEREOF
#506ANHYDROUS DEPIGMENTING COMPOSITIONS COMPRISING, WITHIN THE FATTY PHASE THEREOF, A SOLUBILIZED PHENOLIC COMPOUND AND A RETINOID
#507Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide
#508Foamable suspension gel
#509Cosmetic compositions
#510METHODS FOR TREATING CANCERS USING POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
#511METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS
#512CELASTROL, GEDUNIN, AND DERIVATIVES THEREOF AS HSP90 INHIBITORS
#513METHODS OF TREATING INFLAMMATORY DISORDERS
#514MOLECULAR MODULATORS OF THE WNT/BETA-CATENIN PATHWAY
#515Formulation for retinoid-containing soft gelatin capsules
#516Methods of Use To Orally and Topically Treat Acne and Other Skin Conditions By Administering a 19-NOR Containing Vitamin D Analog With or Without a Retinoid
#517Assay
#518Concurrent therapy regime/regimen for the treatment of acne related diseases
#519Topical skin care composition
#520WOUND HEALING
#521METHOD FOR TREATING THE HYPERPIGMENTATION OF PATHOLOGICAL SCARS
#522MICROPARTICLES
#523USE OF ALKANEDICARBOXYLIC ACIDS AND RETINOIDS FOR TREATMENT OF ROSACEA AND OTHER INFLAMMATORY SKIN DISEASES
#524ANHYDROUS PETROLEUM JELLY/ELASTOMER-FREE DEPIGMENTING COMPOSITIONS COMPRISING A SOLUBILIZED PHENOLIC COMPOUND AND A RETINOID
#525STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT
#526Low toxicity topical active agent delivery system
#527Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#528ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#529Method of enhancing transdermal absorption using a composition comprising POE octyl dodecyl ether and squalane
#530THERAPEUTIC AGENT FOR LOCAL INFLAMMATION
#531Alpha 5 beta 1 and its ability to regulate the cell survival pathway
#532RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED MATTERS
#533ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#534Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
#535ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#536Methods and compositions for the dietary management of autoimmune disorders
#537Compositions and methods for treating macular degeneration
#538ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
#539Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
#540Vitamin formulation
#541Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis
#542Diffusion enhancing compounds and their use alone or with thrombolytics
#543FACTOR
#544Nutraceutical composition and methods for preventing or treating multiple sclerosis
#545COMPOSITION AND METHOD FOR TREATING ACNE
#546PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME
#547PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME
#548ENHANCEMENT OF THE EFFICACY OF THERAPEUTIC PROTEINS
#549Quinone derivatives, pharmaceutical compositions, and uses thereof
#550ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#551Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
#552METHODS AND COMPOSITIONS FOR TREATING SKIN CONDITIONS
#553Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
#554Remedy for the treatment of cardio-vascular diseases or disorders
#555Anti-angiogenic nanoparticle compositions
#556Topical foam composition
#557IRAK-1 AS REGULATOR OF DISEASES AND DISORDERS
#558DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE
#559Means and methods for the recruitment and identification of stem cells
#560Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy
#561Cream gels comprising at least one retinoid and benzoyl peroxide
#562DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE
#563Methods of treating skin disorders with caffeic acid analogs
#564Dermatological/cosmetic skin depigmenting compositions
#565Formulation for retinoid-containing soft gelatin capsules
#566Methods for treating metabolic diseases
#567TOPICAL SKIN CARE COMPOSITION
#568Method for inhibiting liver fibrosis via retinoic acid derivative
#569Compositions and Methods for Treating or Preventing Ophthalmic Disease
#570NOVEL USE OF ANTIDEPRESSANT COMPOUNDS AND RELATED COMPOSITIONS
#571MODULATION OF SIGNAL TRANSDUCTION
#572Photodynamic therapy for the treatment of acne
#573COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING A PEROXIDE AND RETINOID
#574INHIBITION OF BIOFILM FORMATION
#575TOPICAL AQUEOUS COMPOSITION COMPRISING TRETINOIN
#576Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy
#577IMPROVEMENTS IN RELATION TO CANCER THERAPY
#578Method and process for producing youthful-appearing, small-pored, and smooth skin
#579Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide
#580METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS
#581COMPOSITION AND USE OF RAR ANTAGONISTS FOR PROMOTING CHONDROGENESIS
#582Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy
#583Composition Designed For The Treatment Of Multiple Sclerosis
#584Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent
#585COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#586ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES
#587Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
#588PHARMACEUTICAL FOR PREVENTION AND TREATMENT OF OPHTHALMIC DISEASE INDUCED BY IN-CREASE IN VASOPERMEABILITY
#589Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition
#590COMPOSITIONS AND METHODS FOR SKIN CARE
#591Compounds and methods for the treatment of cancer
#592Method for treating inflammation
#593Neuroprotection of retinal ganglion cells
#594Methods and compositions for topical treatment of medical conditions including wounds and inflammation
#595USE OF RXR AGONISTS FOR THE TREATMENT OF OSTEOARTHRITIS
#596Treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors
#597Diagnostic assay for the specific treatment of acute myeloid leukemia
#598Biocompatible hydrogel compositions
#599METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS
#600RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS